We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Top Sells

Rank Stock Value
1
MDP
Meredith Corporation
MDP
+$2.9M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.77M
3
CLFD icon
Clearfield
CLFD
+$2.59M
4
QCOM icon
Qualcomm
QCOM
+$2.5M
5
TRTN
Triton International Limited
TRTN
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISH
176
DELISTED
DISH Network Corp.
DISH
$843K 0.19%
+26,000
New +$969K
QDEL icon
177
QuidelOrtho
QDEL
$1.11B
$837K 0.18%
6,200
– –
CHS
178
DELISTED
Chicos FAS, Inc.
CHS
$829K 0.18%
154,000
– –
PBI icon
179
Pitney Bowes
PBI
$2.46B
$822K 0.18%
124,000
– –
AMAT icon
180
Applied Materials
AMAT
$419B
$818K 0.18%
5,200
-5,200
-50% -$753K
AR icon
181
Antero Resources
AR
$10.7B
$814K 0.18%
46,500
– –
THO icon
182
Thor Industries
THO
$4.04B
$809K 0.18%
+7,800
New +$846K
LGND icon
183
Ligand Pharmaceuticals
LGND
$6.02B
$803K 0.18%
+8,336
New +$770K
EXPR
184
DELISTED
Express, Inc.
EXPR
$801K 0.18%
13,000
-7,150
-35% -$562K
HAL icon
185
Halliburton
HAL
$27.1B
$800K 0.18%
35,000
– –
MRK icon
186
Merck
MRK
$317B
$797K 0.17%
+10,400
New +$828K
HOLX
187
DELISTED
Hologic
HOLX
$796K 0.17%
10,400
-8,200
-44% -$603K
MAC icon
188
Macerich
MAC
$6.66B
$795K 0.17%
+46,000
New +$862K
OLLI icon
189
Ollie's Bargain Outlet
OLLI
$4.71B
$793K 0.17%
15,500
– –
CRSP icon
190
CRISPR Therapeutics
CRSP
$4.99B
$788K 0.17%
10,400
-2,000
-16% -$175K
FOR icon
191
Forestar Group
FOR
$1.49B
$783K 0.17%
36,000
– –
SONO icon
192
Sonos
SONO
$1.83B
$775K 0.17%
26,000
-20,500
-44% -$652K
PRTA icon
193
Prothena Corp
PRTA
$449M
$771K 0.17%
+15,600
New +$865K
HOPE icon
194
Hope Bancorp
HOPE
$1.78B
$765K 0.17%
+52,000
New +$768K
BBBY
195
DELISTED
Bed Bath & Beyond Inc
BBBY
$758K 0.17%
52,000
-10,000
-16% -$175K
VLO icon
196
Valero Energy
VLO
$87.2B
$751K 0.16%
10,000
– –
HBB icon
197
Hamilton Beach Brands
HBB
$366M
$747K 0.16%
52,000
+12,900
+33% +$198K
KMB icon
198
Kimberly-Clark
KMB
$36.1B
$743K 0.16%
5,200
-1,000
-16% -$135K
BRBR icon
199
BellRing Brands
BRBR
$1.41B
$742K 0.16%
26,000
-20,500
-44% -$536K
ORLY icon
200
O'Reilly Automotive
ORLY
$76.2B
$742K 0.16%
15,750
– –
6 7
8
9 10

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.